Miami Talc Trial: When a Product You Trusted for Decades Turns Out to Be the Thing That Killed Her
If you are reading this because someone you love used Johnson & Johnson Baby Powder for years and then died of ovarian cancer, you already know the hardest part: nobody warned you. Nobody warned her. A retired doctor — a physician who spent her career inside hospitals — used a product marketed to her since childhood for daily feminine hygiene, and if the evidence in this Miami courtroom is what the family says it is, the company that sold it knew it contained asbestos and said nothing. That is why we are writing this page. Not to report on a trial, but to tell you what your family’s situation means, what the law allows, what the evidence looks like, how the deadline works, and what a case like yours is honestly worth.
We are Attorney911 — The Manginello Law Firm, PLLC. We handle toxic tort cases and wrongful death claims, and we write this page as the trial attorneys we are — in first person, to one person, with nothing held back. Everything below is legal information, not legal advice. Past results depend on the facts of each case and do not guarantee future outcomes. But the information itself is free, and so is the call: 1-888-ATTY-911.
The Miami Retrial: What This Case Is Really About
In the Eleventh Judicial Circuit Court in Miami-Dade County — one of the busiest and most significant trial venues in the southeastern United States for product liability litigation — a wrongful death retrial is underway. The case is Sugarman v. Johnson & Johnson, docket number 2019-CA-017627. A husband lost his wife to ovarian cancer. She was 69 years old, a retired anesthesiologist named Marilyn Seskin, and she died in 2019. For decades she used Johnson & Johnson’s talc-based Baby Powder for personal hygiene — exactly as the company marketed it.
This is the second time this case has been tried. The first trial ended in a deadlocked jury — a hung jury that could not agree. That fact matters to you for two reasons. First, it means at least some jurors found the evidence strong enough to prevent a defense verdict — a hung jury is not a loss; it is a fight that was close enough that the case lives on. Second, it tells both sides exactly which arguments resonated and which fell flat, making this retrial a refinement battle where the margins may decide everything.
The plaintiff alleges that asbestos contamination in J&J’s talc-based Baby Powder caused Marilyn Seskin’s ovarian cancer, and that J&J knew of the asbestos presence and cancer risk for decades but failed to warn consumers — instead engaging in a campaign to discredit scientific findings linking talc to cancer. The defense contends its talc is safe, that none of the decedent’s medical records identify talc as the cause, and that the most reliable epidemiological studies show no causal link.
“If Johnson & Johnson had told the truth about its Baby Powder, that it contained asbestos and caused cancer, this didn’t have to happen.”
That is what the family’s attorney told the jury in opening statement. It is the core of the case: not that the product might have been dangerous, but that the company allegedly knew it was and chose silence over warning.
Talc and Asbestos: The Geological Connection That the Company Understood and the Public Did Not
To understand why this case exists, you need to understand one geological fact that most consumers never learned: talc and asbestos are minerals that form together in the earth. They are neighbors in the ground. Talc deposits frequently contain asbestos contamination — including tremolite, anthophyllite, and chrysotile — because the geological conditions that create talc also create asbestos. When you mine talc, you cannot assume it is free of asbestos unless you test for it, separate it, and certify its purity. That is geology, not speculation.
Asbestos is classified as a known human carcinogen by the International Agency for Research on Cancer — IARC Group 1, the highest certainty category, reserved for substances proven to cause cancer in humans. Multiple federal agencies classify it the same way. The Environmental Protection Agency regulates asbestos under the Toxic Substances Control Act. The Occupational Safety and Health Administration regulates it in workplace settings. The science that asbestos causes cancer is not disputed.
What is disputed in this courtroom is whether the asbestos contamination in cosmetic talc — at the levels found in Baby Powder — is sufficient to cause ovarian cancer through decades of perineal use. The defense argues that documents showing the presence of tremolite in the talc do not mean the talc contained tremolite asbestos, because tremolite occurs in both asbestos and non-asbestos mineral forms. That is a real scientific distinction, and it is the exact seam the defense exploits. The plaintiff’s answer requires a qualified mineralogist who can distinguish asbestiform tremolite from non-asbestiform tremolite and testify that the fibers found in J&J’s talc were the kind that cause cancer.
The mechanism the plaintiff must prove is not inhalation — it is migration. The theory is that asbestos fibers in talc applied to the perineal area can travel through the vagina, cervix, uterus, and fallopian tubes to the ovaries, where decades of chronic irritation and genotoxic damage can initiate the cellular mutation that becomes ovarian cancer. This is the specific-causation fight. It is the hardest part of the case, and it is exactly where the first jury deadlocked.
What Johnson & Johnson Allegedly Knew — and When They Allegedly Knew It
The plaintiff has previewed evidence showing that J&J possessed internal knowledge of asbestos contamination in its talc products for decades. The core of the failure-to-warn theory is not that the company should have known — it is that the company did know and chose not to tell.
The evidence category includes J&J’s internal corporate documents regarding talc testing, asbestos detection, and risk assessments. These documents — produced in discovery and now being presented to the jury — are the spine of both the failure-to-warn claim and the punitive damages claim. If the jury credits this evidence, it does more than establish liability. It establishes a culpable state of mind — the difference between a company that made a mistake and a company that allegedly made a choice.
Beyond the testing documents, the plaintiff alleges that J&J engaged in a deliberate, sustained campaign to deny and discredit scientific findings linking talc to cancer. This is the fraudulent-concealment theory: not just silence, but active suppression. If proven, it transforms the case from a product liability claim into something that looks more like fraud — and fraud is what drives punitive damages.
J&J pulled its talc-based products from the U.S. and Canadian markets in 2020. It completed the worldwide removal of talcum powder from its products in 2023. The company did not recall the product. It withdrew it. A recall is an admission; a withdrawal can be framed as a business decision. That distinction is the defense’s, and the jury will decide what it means.
The Regulatory Gap: Why the FDA Did Not Stop This
Here is something the company is counting on you not understanding: the federal regulatory system for cosmetics is not what most people think it is. Cosmetic products containing talc fall under the Federal Food, Drug, and Cosmetic Act — but that law does not require premarket FDA approval or safety substantiation for cosmetics. The FDA does not test cosmetic talc for asbestos before it reaches your bathroom shelf. The agency historically issued advisories about potential asbestos contamination in cosmetic talc, but it lacked mandatory testing authority and lacked mandatory recall authority for cosmetics.
What this means in plain language: the company that made the powder was responsible for testing its own talc for asbestos. The government did not do it for them. The government did not require proof of safety before the product went to market. This was a self-policing regime — and the plaintiff’s argument is that J&J exploited exactly that gap, knowing the FDA would not catch what the company chose not to report.
The Modernization of Cosmetics Regulation Act of 2022 expanded certain FDA oversight authorities over cosmetics, including facility registration and adverse event reporting. But during the decades of Marilyn Seskin’s product use, the regulatory framework was effectively a trust system. The burden of asbestos testing and consumer warning sat squarely on the manufacturer — and the plaintiff says that is exactly where the failure occurred.
This regulatory gap is not a defense for J&J. It is the context that makes the failure-to-warn theory stronger. When no government agency is checking, the manufacturer’s own knowledge and its own duty to warn become the entire case.
Florida Product Liability Law in Toxic Tort Cases
Florida product liability law recognizes strict liability for defective products under the Restatement (Second) of Torts § 402A framework. That means a plaintiff can hold a manufacturer responsible without proving the manufacturer was careless — if the product was defective and unreasonably dangerous. Florida recognizes three categories of product defect: manufacturing defect, design defect, and failure to warn.
In this case, the central liability theory is failure to warn. The allegation is that J&J possessed actual knowledge for decades that its talc contained asbestos and posed a cancer risk but failed to provide adequate warnings to consumers. Under Florida law, a manufacturer has a duty to warn of known or reasonably foreseeable dangers associated with the use of its product. When the danger is known to the manufacturer and the consumer is not warned, the product is defective — not because it was built wrong, but because it was sold without the information that would have let the consumer decide whether to use it at all.
The design-defect theory runs parallel: asbestos-contaminated talc rendered Baby Powder unreasonably dangerous, and safer alternative formulations — asbestos-free talc sourcing or cornstarch-based substitutes — were technologically and economically feasible during the period of use. J&J itself eventually switched to cornstarch. The question the jury must answer is why it took so long.
The negligence theory — failure to test and monitor — alleges that J&J failed to implement adequate testing protocols to detect and eliminate asbestos contamination in its talc supply chain despite awareness of the geological co-occurrence of talc and asbestos. A company that mines a mineral known to co-occur with a carcinogen has a duty to test for that carcinogen. If it does not, the absence of testing is not an absence of knowledge — it is a choice not to look.
Florida applies a pure comparative negligence standard. In a product liability case where the consumer used the product exactly as marketed and intended, comparative fault has limited application — but the defense may still argue that the decedent assumed a risk she should have recognized, or that alternative causes of her cancer were more likely. Every percentage point of fault the defense can pin on the plaintiff reduces the recovery. That is exactly why the defense fights so hard on causation.
Wrongful Death in Florida: Who Can File and What They Can Recover
Florida’s Wrongful Death Act provides the statutory mechanism for a surviving spouse to recover damages after a death caused by another’s negligence or defective product. Robert Sugarman, as Marilyn Seskin’s husband, brings this case as the personal representative of her estate and as the surviving spouse.
Under Florida’s wrongful death framework, the recoverable damages include the lost support, services, and companionship the survivor has been deprived of. The estate may also pursue a survival claim for the decedent’s own pain and suffering during the period between injury and death — the months or years of cancer treatment, surgery, chemotherapy, and decline that Marilyn Seskin endured before she died.
The economic damages in a case like this are substantial. Ovarian cancer treatment typically involves cytoreductive debulking surgery, platinum-based chemotherapy regimens — carboplatin and paclitaxel — potential PARP inhibitor maintenance therapy, and palliative care in advanced-stage disease. The medical expenses alone run into the hundreds of thousands. Add funeral expenses, the loss of Seskin’s continued financial contributions and retirement benefits to her surviving spouse, and the economic stream is significant.
The non-economic damages — mental pain and suffering of the surviving husband, loss of spousal companionship and consortium, and Seskin’s own suffering during disease progression — are where the human cost lives. Ovarian cancer is among the most lethal gynecologic malignancies, typically diagnosed at advanced stages with a five-year survival rate below fifty percent. It carries profound physical and psychological morbidity. The decedent’s professional status as a retired anesthesiologist — medically sophisticated, yet allegedly unaware of asbestos risk in a consumer product marketed for daily personal hygiene — reinforces the failure-to-warn theory. If a doctor did not know, how was a consumer supposed to?
The decedent’s professional status matters in another way: it rebuts the defense argument that the risk was obvious. It was not obvious. It was hidden — if the plaintiff’s evidence is credited — by the very company that knew.
Punitive Damages in Florida: The Value Multiplier
Florida’s punitive damages statute requires an evidentiary showing of intentional misconduct or gross negligence before a punitive damages claim may be presented to the jury. This is not automatic. The plaintiff must make a threshold showing — and in this case, the corporate-knowledge and concealment evidence is exactly what that showing requires.
If the jury finds that J&J possessed actual knowledge of asbestos contamination and deliberately concealed it — that the company knew its Baby Powder contained a carcinogen and chose not to warn consumers, regulators, or the medical community — that is the predicate for punitive damages. Punitive damages are not compensation for a loss. They are punishment for conduct that society has decided deserves more than a compensatory verdict.
Punitive damages are the primary value multiplier in this case. The compensatory damages — the medical bills, the lost support, the pain and suffering — are the foundation. But if the jury credits the concealment evidence, the punitive award could substantially exceed the compensatory recovery and push the total verdict toward the upper range of the case-value analysis.
Florida has procedural requirements and potential statutory limitations on punitive damages that must be confirmed for the current legal landscape — the rules in this area can change. But the doctrine is clear: intentional misconduct or gross negligence opens the door to punishment damages, and the evidence in this case is built to walk through that door.
The prior hung jury is a material factor here. It signals that specific causation is genuinely contested — that at least some jurors found the defense “no causation, no case” framing persuasive. That limits the probability of a maximum-end verdict. But Miami-Dade’s jury pool is among the most demographically diverse in the country, and the venue has historically produced plaintiff-friendly outcomes in cases featuring strong corporate-concealment evidence. The combination is what makes this retrial genuinely uncertain — and genuinely significant.
The Daubert Battlefield: Expert Evidence in Talc Cases
Florida adopted the Daubert standard for expert witness testimony, making the admissibility of causation experts a critical pretrial and trial battleground in toxic tort cases where general and specific causation are contested.
Daubert requires the trial judge to serve as a gatekeeper — to evaluate whether expert testimony is based on sufficient facts or data, is the product of reliable principles and methods, and reflects a reliable application of those principles to the facts of the case. In a talc ovarian cancer case, this plays out across three expert categories:
The mineralogist must distinguish asbestiform tremolite from non-asbestiform tremolite and testify to asbestos detection in J&J talc. This is the product-identification expert — the one who can tell the jury that the fibers in the powder were the kind that cause cancer, not just any mineral that shares a name with asbestos.
The epidemiologist must establish general causation — that talc and asbestos exposure can cause ovarian cancer in human populations, not just in laboratory conditions. This expert faces the defense’s strongest challenge, because the epidemiological literature on talc and ovarian cancer is mixed. Some studies show an association; others do not. The defense will present its own epidemiologists who will testify that the most reliable studies show no causal link.
The treating or consulting oncologist must bridge general causation to specific causation — this decedent’s exposure pattern caused her disease. This expert must explain why the absence of a talc causation notation in Seskin’s medical records does not mean the absence of causation. Doctors treating ovarian cancer do not typically investigate the patient’s decades-long talc use as a potential cause — they treat the cancer. The absence of a talc notation in the chart is standard medical practice, not evidence that talc did not cause the disease.
This is the defense’s central argument: no causation, no case. The defense told jurors exactly that in opening statement. The plaintiff’s counter requires a coherent mechanistic narrative linking decades of perineal talc application to ovarian cancer through asbestos fiber migration, supported by qualified experts who survive Daubert. That narrative is what the first jury deadlocked on. It is what this retrial must deliver.
The Corporate Shell Game: J&J’s Structure and the Bankruptcy Strategy
Johnson & Johnson is not one company. It is a corporate family, and understanding its structure matters because it explains both why the cases are so numerous and why the company has fought so hard to avoid resolving them.
The talc liability has been shuffled through a chain of entities. Johnson & Johnson Consumer Inc. was the historical talc seller. LTL Management LLC was the entity created in what critics call a “Texas two-step” divisional merger to hold talc liability — it filed Chapter 11 bankruptcy twice, and both attempts were dismissed. Red River Talc LLC was the renamed successor liability vehicle used for a third bankruptcy attempt. On March 31, 2025, the U.S. Bankruptcy Court for the Southern District of Texas denied confirmation and dismissed that prepackaged Chapter 11 — J&J’s third failed bankruptcy bid. The court found vote-solicitation irregularities and impermissible nonconsensual third-party releases.
Three times the company tried to wall these cases off inside a bankruptcy it created on purpose. Three times a court threw it out. The cases are back in the regular court system — and the number of cases is staggering.
As of June 2026, the JPML’s pending docket report shows MDL-2738 — In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation — with 68,029 actions pending in the District of New Jersey before Judge Michael A. Shipp. More than 68,000 cases. That is not a typo. It is the scale of what the company is facing, and it is the scale of what the company was trying to escape through bankruptcy.
Kenvue Inc. is the consumer-health spinoff from J&J — the entity that now holds brands like Band-Aid, Tylenol, and Listerine. The corporate separation between J&J and Kenvue, and the indemnity arrangements between them, are part of the structure that complicates recovery. The case caption identifies additional defendants beyond J&J itself — typically including corporate subsidiaries, consumer products divisions, and potentially talc suppliers. The shell game is not just about who pays. It is about who is legally answerable for the decision to sell a powder that, if the plaintiff’s evidence is credited, the company knew was contaminated.
The verdict history in this litigation is real and significant. In one case, 22 women took J&J to trial over talcum powder. The jury came back with $4.69 billion. Appeals courts later reduced that to approximately $2.1 billion. In 2021, the United States Supreme Court declined to review the reduced award — meaning the $2.1 billion stands as a final, affirmed verdict. That is not a press release. That is a number the highest court in the country let stand.
The Medicine: Ovarian Cancer, Asbestos, and the Causation Fight
Ovarian cancer is among the most lethal gynecologic malignancies. It is typically diagnosed at advanced stages because early symptoms are vague — bloating, pelvic pain, changes in bowel habits, urinary urgency — symptoms that mirror common conditions and delay diagnosis until the disease has spread beyond the ovaries. The five-year survival rate is below fifty percent for advanced-stage disease. For a woman diagnosed at Stage III or IV, the prognosis is often measured in months to a few years.
The treatment is brutal. Cytoreductive debulking surgery removes as much visible tumor as possible — the ovaries, fallopian tubes, uterus, and often omentum, plus any peritoneal implants the surgeon can reach. Platinum-based chemotherapy follows — carboplatin and paclitaxel, typically six cycles, with their well-known toxicities: neuropathy, hair loss, bone-marrow suppression, nausea, fatigue. For some patients, PARP inhibitor maintenance therapy follows — a daily pill that can extend remission but brings its own side-effect profile. For advanced disease that does not respond, the treatment pathway runs through more chemotherapy, clinical trials, and eventually palliative care.
This is what Marilyn Seskin went through. This is the pain and suffering that the survival claim is built on. And this is what the defense must argue was caused by something other than the product she used for decades — genetics, environmental factors, reproductive history, or simply bad luck. The defense says the medical records do not mention talc as a cause. The plaintiff says the medical records do not mention talc because no doctor was looking for it — and the reason no doctor was looking is that the company that knew about the asbestos did not tell anyone.
The latency problem is real. Ovarian cancer from asbestos exposure, if it occurs, takes years to decades to develop — consistent with Marilyn Seskin’s decades of product use before her 2019 diagnosis. But latency cuts both ways: it makes it harder to prove that this specific exposure caused this specific cancer, because the body’s record of what it encountered thirty years ago is not as clean as a lab experiment. The plaintiff’s experts must reconstruct the dose and the timeline. The defense’s experts will argue the reconstruction is speculation.
The proof problem is the absence of a “talc” notation in the medical records. The defense will point to this absence and call it proof that the cancer had other causes. The counter — and it must come from a qualified oncologist on the witness stand — is that the absence of a talc causation notation in medical treatment records is the standard presentation, not the exception. Oncologists diagnose and treat; they do not typically investigate decades-long consumer product use as an etiology unless someone specifically raises it. The records are silent because nobody asked the question — and nobody asked the question because the company that had the answer did not share it.
Damages: What a Talc Wrongful Death Case Is Worth
The case-value analysis for a talc ovarian cancer wrongful death case is built on two layers: the compensatory foundation and the punitive multiplier.
The compensatory layer includes economic and non-economic damages. Economic damages cover the substantial medical expenses associated with ovarian cancer treatment — surgery, chemotherapy, potential PARP inhibitor therapy, palliative care — along with funeral expenses and the loss of the decedent’s continued financial contributions and retirement benefits to the surviving spouse. For a retired physician, the retirement-benefit loss alone can be significant.
Non-economic damages cover the surviving spouse’s mental pain and suffering, loss of companionship and consortium, and the decedent’s own pain and suffering during the disease progression period under Florida’s survival framework. These are the human costs — the empty chair, the lost future, the months of treatment endured — and they are where the jury’s judgment, not a formula, determines value.
The punitive layer is the primary value driver. If the jury credits the evidence of J&J’s alleged decades-long knowledge of asbestos contamination and deliberate concealment campaign, the punitive award could substantially exceed the compensatory recovery. The combination of Miami-Dade’s plaintiff-friendly venue and the corporate-concealment evidence supports the higher end of the range.
Based on the case profile — wrongful death of a retired physician with documented advanced ovarian cancer treatment, contested specific causation, and significant punitive exposure — the case value range runs from approximately $5 million on the low end to $50 million on the high end. The low end assumes a plaintiff verdict with limited punitive damages. The high end assumes the jury credits the full concealment narrative and imposes a significant punitive award. The prior hung jury is a material deflator — it signals genuine outcome uncertainty and limits the probability of a maximum-end verdict. But a maximum-end verdict is possible if the retrial closes the specific-causation gap that the defense exploited the first time.
Comparable talc ovarian cancer wrongful death verdicts nationally have reached into the tens of millions, though outcomes vary widely based on venue, causation evidence strength, and the specific punitive damages framework applicable. The $2.1 billion Ingham verdict — affirmed by the Supreme Court’s denial of certiorari — is the ceiling reference, though that was a multi-plaintiff case, not a single wrongful death.
We tell you this range honestly. We do not promise a number. We do not guarantee an outcome. What we can tell you is what the evidence supports, what the venue permits, and what the defense will fight hardest to take away.
Evidence That Disappears — and How to Save It
In a toxic tort case, the evidence that proves exposure often exists on a clock — and the clock is shorter than most families realize. Here is what exists, who holds it, and how fast it can die:
The product itself. Baby Powder containers and any remaining product samples are the physical evidence for mineralogical and electron-microscopy testing for asbestos fibers. This establishes the exposure source and product identification. Consumer product containers are routinely discarded. They degrade. They get lost over the years-long timeline of litigation. If the family has the actual containers the decedent used, they must be preserved. If they do not, the case depends on product-identification through purchase records and testimony.
The medical and oncology records. The complete treatment history documents the cancer diagnosis, histological subtype, treatment history, disease progression, and prognosis timeline. These records are immutable — historical medical records do not change. But the defense emphasizes the absence of any talc causation notation in these records, and the plaintiff must explain that absence through expert testimony.
Expert mineralogical analyses. The bridge between general causation and specific causation — the scientific evidence that asbestos was in the product and that asbestos can cause this cancer — lives in expert reports and Daubert rulings completed pretrial. This evidence has already been through the admissibility fight. It is preserved in the court record.
J&J internal corporate documents. The core proof of actual knowledge and concealment — testing memos, asbestos detection results, risk assessments, marketing materials without warnings — these have been produced in discovery and are being presented at trial. They are preserved for this proceeding.
Marketing, advertising, and promotional materials. The Baby Powder campaigns that demonstrate how the product was marketed for feminine hygiene and daily personal care use — without asbestos or cancer warnings — are historical corporate materials preserved through discovery.
Deposition transcripts. J&J executives, scientists, and regulatory personnel have been deposed, and their testimony is locked in the court record for impeachment and cross-examination at retrial.
If you are considering a talc case of your own — not this Miami case, but your own situation — the evidence-preservation clock is running right now. Product containers get thrown away. Family members who know the purchasing history pass away. Medical records get archived. The preservation letter that freezes evidence goes out the day you call — not after the insurance company contacts you, not after you “think about it,” not after the two-year deadline starts pressing. The day you call.
The Defense Playbook: What J&J’s Lawyers Will Do
Johnson & Johnson is represented by some of the most sophisticated defense counsel in the country. In this Miami retrial, the defense has already shown its hand. Here are the plays they are running, and the counter to each:
Play 1: “No causation, no case.” The defense has built its entire strategy on the argument that the plaintiff cannot prove Baby Powder caused this specific cancer. The counter is the mechanistic narrative — a qualified oncologist who explains how asbestos fibers travel from perineal application to the ovaries, supported by the mineralogist who identifies asbestos in the product and the epidemiologist who establishes general causation. The absence of a talc notation in the medical records is explained as standard medical practice, not as evidence against causation.
Play 2: “The medical records don’t mention talc.” The defense emphasizes that none of Seskin’s treatment records identified talc as the cause. The counter is the oncologist’s testimony that treating physicians do not typically investigate consumer product etiology — they diagnose and treat. The silence in the chart is the silence of a medical system that was never told what to look for.
Play 3: “The most reliable studies show no link.” The defense cites epidemiological studies that show no association between talc and ovarian cancer. The counter is the plaintiff’s own epidemiological evidence — studies that do show an association — and the argument that the most reliable studies are the ones that properly account for asbestos contamination, not the ones that treat talc as a uniform substance.
Play 4: “Tremolite is not necessarily asbestos.” The defense argues that documents showing tremolite in the talc do not prove asbestos contamination because tremolite exists in non-asbestiform varieties. The counter is the mineralogist who can distinguish asbestiform from non-asbestiform tremolite and testify to the specific fiber type found.
Play 5: The corporate-knowledge evidence is old and out of context. The defense will attempt to minimize the internal documents by arguing they are historical, were addressed by subsequent testing, or do not reflect current scientific understanding. The counter is the timeline — the decades between what the company allegedly knew and when it withdrew the product from the market.
Each play has a counter, but the counters require the right experts, the right evidence, and the right trial strategy. That is what a trial is — not a list of arguments, but a structured presentation of proof that survives cross-examination and resonates with twelve people who did not ask to be in that courtroom.
Your First 72 Hours: What to Do Now
If your situation is like this one — a family member used talc-based Baby Powder for years and later developed ovarian cancer or died — here is what the first days look like, and what you should and should not do:
Do seek medical care first. If you are the person who used the product and you have not yet been evaluated, your health is the priority. Ovarian cancer symptoms are vague and mimic common conditions. If you have persistent bloating, pelvic pain, urinary urgency, changes in bowel habits, or feeling full quickly when eating, see a physician. Tell them about your talc use history. That information — in the medical record — matters.
Do not give a recorded statement to anyone from the company or its representatives. If someone contacts you claiming to represent Johnson & Johnson or its insurers, do not speak with them. Anything you say can be used to build a defense against your claim. Refer all communication to counsel.
Do preserve the product. If you still have Baby Powder containers — yours, your mother’s, your sister’s — save them. Do not throw them away. Do not open them. Store them safely. The physical product can be tested for asbestos fibers, and that testing is a foundational piece of product-identification proof.
Do document the usage history. Write down everything you can remember: which brands, how often, how many years, for what purpose. Talk to family members who can corroborate. This information fades with time, and it is the evidence of exposure that no database can replace.
Do not sign anything. No releases, no waivers, no settlements, no authorizations for medical records — nothing. If someone offers you money quickly, understand that a fast settlement offer before the full extent of harm is known is not generosity. It is a business decision designed to close your claim for less than it is worth.
Do check the deadline. Florida’s wrongful death statute of limitations is generally two years from the date of death. For a personal injury claim (if the injured person is still alive), the deadline is shorter than it used to be — Florida reformed its negligence statute of limitations, and the current period must be confirmed for your specific situation. Toxic tort cases may involve a discovery rule — the clock may start when you discovered or should have discovered the connection between the product and the disease, not when you were exposed. But you should never assume the discovery rule saves you. You should never assume you have plenty of time. The deadline is real, and missing it ends the case permanently.
Do call a lawyer. Not next month. Not after the trial in Miami is over. Now. The preservation letter that freezes evidence goes out the day you call. The product testing that proves asbestos contamination is arranged the day you call. The expert witnesses who will testify to causation are retained the day you call. Everything else — the investigation, the records, the case building — follows from that first call.
Why This Firm
We are Attorney911 — The Manginello Law Firm, PLLC. We take toxic tort, product liability, and wrongful death cases. We work on contingency: 33.33% before trial, 40% if the case goes to trial. We do not get paid unless we win your case. The consultation is free. The call is free. The conversation costs you nothing and may change everything.
Ralph Manginello is our Managing Partner. He has spent 27+ years in courtrooms, including federal court. He is admitted to the U.S. District Court, Southern District of Texas. He was a journalist before he was a lawyer — which means he knows how to find the story the evidence tells, and he knows how to tell it to a jury. He leads our active $10 million hazing lawsuit against the University of Houston and Pi Kappa Phi fraternity. He does not lose cases quietly. You can read more about Ralph here.
Lupe Peña is our associate attorney. He spent years inside a national insurance-defense firm — the rooms where adjusters and their software decided how to deny, delay, and devalue claims exactly like yours. He knows how the other side values a case because he used to be the one doing the valuing. He is fluent in Spanish and conducts full consultations in Spanish without an interpreter. He is a third-generation Texan who now fights for the people he used to be paid to fight against. You can read more about Lupe here.
We are not counsel of record in the Miami retrial. We did not file this case and we do not represent these parties. What we are is a trial firm that handles cases like this one — that knows the medicine, the law, the evidence, the defendant, and the fight. We are a resource for you, and we are a phone call away.
If you are reading this at 2 a.m. — if you found us because you are scared, or grieving, or angry, or all three — that is exactly when we are here. Our hotline is staffed 24 hours a day, 7 days a week, by live people. Not an answering service. Call 1-888-ATTY-911. Or contact us here. We will talk to you in English or in Spanish. We will tell you honestly whether you have a case and what it is worth. And if we are not the right fit for your situation, we will tell you that too.
Frequently Asked Questions
Can I sue Johnson & Johnson if my loved one used Baby Powder and died of ovarian cancer?
You may have a claim if the product was used for a significant period — typically years to decades — in the perineal area, and the diagnosis is ovarian cancer. The claim depends on establishing exposure, general causation (talc/asbestos can cause ovarian cancer), and specific causation (this exposure caused this cancer). Each case turns on its own facts — the duration and frequency of use, the availability of product containers or purchase evidence, the medical records, and the strength of the expert testimony. The statute of limitations is a hard deadline, so the first question is not whether you have a case but whether you still have time to file one.
How long do I have to file a talcum powder lawsuit in Florida?
Florida’s wrongful death statute of limitations is generally two years from the date of death. For a personal injury claim by a living person diagnosed with ovarian cancer, the limitation period is shorter than it once was following Florida’s tort reform, and the current period must be confirmed for your specific situation. In toxic tort cases, some courts apply a discovery rule — meaning the clock may start when you discovered or should have discovered the connection between the product and the disease. But the discovery rule is not guaranteed, and some states impose an outer deadline that can cut off a claim even before discovery. Never assume you have plenty of time. Confirm the deadline for your state and your facts with a lawyer immediately.
What if my loved one’s medical records don’t mention talc as the cause of cancer?
This is the defense’s favorite argument, and it is misleading. Treating oncologists diagnose and treat cancer; they do not typically investigate decades-long consumer product use as a potential cause unless someone specifically raises it. The absence of a talc notation in medical records is standard medical practice, not evidence that talc did not cause the cancer. A qualified oncologist can testify to this — that the absence of an etiology investigation in the chart is the norm, not proof of alternative causation.
Does the Miami retrial affect my case?
The Miami retrial is a specific case with its own facts and its own jury. Your case would be separate — filed on your own facts, with your own evidence, in your own venue. But the retrial matters to you in two ways: it shows that talc cases can survive even after a hung jury, and whatever verdict it produces will become part of the national landscape that insurers and defense lawyers consider when evaluating cases like yours. A plaintiff verdict in Miami would strengthen settlement leverage across the litigation; a defense verdict would make the fight harder. Either way, your case stands or falls on its own evidence.
What is the talc MDL and how does it affect my case?
The multidistrict litigation — MDL-2738 — is a federal consolidation of more than 68,000 talc cases in the District of New Jersey for pretrial proceedings. Joining the MDL does not merge your case into one big pot. Each plaintiff keeps an individual case; the MDL just centralizes the shared pretrial work — discovery, expert challenges, bellwether trials. If your case is filed in federal court, it may be transferred to the MDL. If it is filed in state court, it may remain in state court. The MDL is a procedural tool, not a settlement — though the pressure of 68,000 consolidated cases is part of what drove J&J’s repeated bankruptcy attempts.
What did Johnson & Johnson know about asbestos in its talc, and when?
The plaintiff’s evidence in this and other talc cases includes internal corporate documents showing that J&J’s own testing detected asbestos in its talc products over a period of decades. The specific documents, their dates, and their contents are trial exhibits — not public summaries. The allegation is that the company knew, failed to warn, and actively worked to discredit scientific findings linking talc to cancer. J&J denies these allegations. The jury in this case will decide what the company knew and what it did with that knowledge.
How much is a talc ovarian cancer case worth?
Case value depends on the facts of each case and does not guarantee future outcomes. Based on the case profile in this Miami retrial — wrongful death of a retired physician with documented advanced ovarian cancer treatment and significant punitive exposure — the analytical range runs from approximately $5 million to $50 million. The compensatory component includes medical expenses, funeral costs, lost support, and non-economic damages for pain and suffering and loss of companionship. The punitive component depends on whether the jury credits the corporate-concealment evidence. A prior hung jury signals genuine uncertainty. The $2.1 billion affirmed Ingham verdict — involving 22 plaintiffs — is the ceiling reference, not a single-case predictor. Your case value depends on your specific facts, your venue, and the strength of your expert evidence.
What evidence do I need for a talcum powder lawsuit?
The key evidence categories are: the product itself (containers, remaining powder) for asbestos testing; purchase or usage history (receipts, subscription records, family testimony) for exposure proof; complete medical records for diagnosis and treatment documentation; and expert testimony from a mineralogist, epidemiologist, and oncologist for causation. Internal corporate documents from J&J — produced in discovery — are the spine of the failure-to-warn and punitive damages claims. The preservation of physical product and usage history is the most time-sensitive element, because consumers routinely discard product containers, and family members who can corroborate usage history may not always be available.
Is it too late to file a talc claim if the exposure was decades ago?
Not necessarily. Toxic tort cases often involve a latency period of years to decades between exposure and disease — ovarian cancer from asbestos exposure can take twenty or more years to develop. Many states apply a discovery rule that starts the statute of limitations when the plaintiff discovered or should have discovered the connection between the product and the disease, rather than on the date of exposure. However, some states also have a statute of repose — an outer deadline that can cut off a claim even before discovery. The only way to know whether you still have time is to have a lawyer check the specific deadline for your state and your facts. Do not assume it is too late. Do not assume you have plenty of time. Confirm it.
What should I do if an insurance adjuster or company representative contacts me?
Do not speak with them. Do not give a recorded statement. Do not sign anything. Do not authorize release of medical records. Refer all communication to a lawyer. Anything you say to a representative of the company or its insurer can and will be used to build a defense against your claim. A fast settlement offer before the full extent of harm is understood is not a favor — it is a business strategy designed to close your claim for less than it is worth. The only conversation you should have about your case is with your own lawyer.
If you or someone you love used talc-based Baby Powder for years and was later diagnosed with ovarian cancer — or if you lost someone to this disease — the evidence clock is running, the deadline is real, and the company on the other side has already built its defense. Call 1-888-ATTY-911. Free consultation. No fee unless we win your case. We serve your family fully in English or in Spanish — Hablamos Español. The call is free. The conversation is honest. And it may be the most important call you make.